ID   UBP14_HUMAN             Reviewed;         494 AA.
AC   P54578; B7Z4N8; J3QRZ5; Q53XY5;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   15-MAR-2017, entry version 168.
DE   RecName: Full=Ubiquitin carboxyl-terminal hydrolase 14;
DE            EC=3.4.19.12;
DE   AltName: Full=Deubiquitinating enzyme 14;
DE   AltName: Full=Ubiquitin thioesterase 14;
DE   AltName: Full=Ubiquitin-specific-processing protease 14;
GN   Name=USP14; Synonyms=TGT;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RA   Deshpande K.L., Katze J.R.;
RT   "tRNA-guanine transglycosylase cDNA from human placenta.";
RL   Submitted (AUG-1995) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16177791; DOI=10.1038/nature03983;
RA   Nusbaum C., Zody M.C., Borowsky M.L., Kamal M., Kodira C.D.,
RA   Taylor T.D., Whittaker C.A., Chang J.L., Cuomo C.A., Dewar K.,
RA   FitzGerald M.G., Yang X., Abouelleil A., Allen N.R., Anderson S.,
RA   Bloom T., Bugalter B., Butler J., Cook A., DeCaprio D., Engels R.,
RA   Garber M., Gnirke A., Hafez N., Hall J.L., Norman C.H., Itoh T.,
RA   Jaffe D.B., Kuroki Y., Lehoczky J., Lui A., Macdonald P., Mauceli E.,
RA   Mikkelsen T.S., Naylor J.W., Nicol R., Nguyen C., Noguchi H.,
RA   O'Leary S.B., Piqani B., Smith C.L., Talamas J.A., Topham K.,
RA   Totoki Y., Toyoda A., Wain H.M., Young S.K., Zeng Q., Zimmer A.R.,
RA   Fujiyama A., Hattori M., Birren B.W., Sakaki Y., Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 18.";
RL   Nature 437:551-555(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-308 (ISOFORM 2).
RC   TISSUE=T-cell;
RA   Heil O., Ebert L., Hennig S., Henze S., Radelof U., Schneider D.,
RA   Korn B.;
RL   Submitted (JUN-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   INTERACTION WITH FANCC.
RX   PubMed=14499622; DOI=10.1016/S0014-4827(03)00261-1;
RA   Reuter T.Y., Medhurst A.L., Waisfisz Q., Zhi Y., Herterich S.,
RA   Hoehn H., Gross H.J., Joenje H., Hoatlin M.E., Mathew C.G.,
RA   Huber P.A.;
RT   "Yeast two-hybrid screens imply involvement of Fanconi anemia proteins
RT   in transcription regulation, cell signaling, oxidative metabolism, and
RT   cellular transport.";
RL   Exp. Cell Res. 289:211-221(2003).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-143, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=T-cell;
RX   PubMed=19367720; DOI=10.1021/pr800500r;
RA   Carrascal M., Ovelleiro D., Casas V., Gay M., Abian J.;
RT   "Phosphorylation analysis of primary human T lymphocytes using
RT   sequential IMAC and titanium oxide enrichment.";
RL   J. Proteome Res. 7:5167-5176(2008).
RN   [9]
RP   ASSOCIATION WITH THE 26S PROTEASOME, AND FUNCTION.
RX   PubMed=18162577; DOI=10.1091/mbc.E07-10-1040;
RA   Koulich E., Li X., DeMartino G.N.;
RT   "Relative structural and functional roles of multiple deubiquitylating
RT   proteins associated with mammalian 26S proteasome.";
RL   Mol. Biol. Cell 19:1072-1082(2008).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [11]
RP   FUNCTION, AND INTERACTION WITH ERN1.
RX   PubMed=19135427; DOI=10.1016/j.bbrc.2008.12.182;
RA   Nagai A., Kadowaki H., Maruyama T., Takeda K., Nishitoh H., Ichijo H.;
RT   "USP14 inhibits ER-associated degradation via interaction with
RT   IRE1alpha.";
RL   Biochem. Biophys. Res. Commun. 379:995-1000(2009).
RN   [12]
RP   INTERACTION WITH CXCR4, FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=19106094; DOI=10.1074/jbc.M808507200;
RA   Mines M.A., Goodwin J.S., Limbird L.E., Cui F.F., Fan G.H.;
RT   "Deubiquitination of CXCR4 by USP14 is critical for both CXCL12-
RT   induced CXCR4 degradation and chemotaxis but not ERK activation.";
RL   J. Biol. Chem. 284:5742-5752(2009).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-143, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [14]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-449, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-143 AND THR-235, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-143, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-52; SER-143; SER-237;
RP   SER-302 AND SER-432, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-143 AND THR-235, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [20]
RP   X-RAY CRYSTALLOGRAPHY (3.2 ANGSTROMS) OF 91-494, CATALYTIC ACTIVITY,
RP   AND ACTIVE SITE.
RX   PubMed=16211010; DOI=10.1038/sj.emboj.7600832;
RA   Hu M., Li P., Song L., Jeffrey P.D., Chenova T.A., Wilkinson K.D.,
RA   Cohen R.E., Shi Y.;
RT   "Structure and mechanisms of the proteasome-associated
RT   deubiquitinating enzyme USP14.";
RL   EMBO J. 24:3747-3756(2005).
CC   -!- FUNCTION: Proteasome-associated deubiquitinase which releases
CC       ubiquitin from the proteasome targeted ubiquitinated proteins.
CC       Ensures the regeneration of ubiquitin at the proteasome. Is a
CC       reversibly associated subunit of the proteasome and a large
CC       fraction of proteasome-free protein exists within the cell.
CC       Required for the degradation of the chemokine receptor CXCR4 which
CC       is critical for CXCL12-induced cell chemotaxis. Serves also as a
CC       physiological inhibitor of endoplasmic reticulum-associated
CC       degradation (ERAD) under the non-stressed condition by inhibiting
CC       the degradation of unfolded endoplasmic reticulum proteins via
CC       interaction with ERN1. Indispensable for synaptic development and
CC       function at neuromuscular junctions (NMJs).
CC       {ECO:0000269|PubMed:18162577, ECO:0000269|PubMed:19106094,
CC       ECO:0000269|PubMed:19135427}.
CC   -!- CATALYTIC ACTIVITY: Thiol-dependent hydrolysis of ester,
CC       thioester, amide, peptide and isopeptide bonds formed by the C-
CC       terminal Gly of ubiquitin (a 76-residue protein attached to
CC       proteins as an intracellular targeting signal).
CC       {ECO:0000269|PubMed:16211010}.
CC   -!- SUBUNIT: Homodimer (Potential). Associates with the 26S
CC       proteasome. Interacts with FANCC, CXCR4 and ERN1.
CC       {ECO:0000269|PubMed:14499622, ECO:0000269|PubMed:19106094,
CC       ECO:0000269|PubMed:19135427, ECO:0000305}.
CC   -!- INTERACTION:
CC       Q08209:PPP3CA; NbExp=3; IntAct=EBI-1048016, EBI-352922;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:19106094}.
CC       Cell membrane {ECO:0000269|PubMed:19106094}; Peripheral membrane
CC       protein {ECO:0000269|PubMed:19106094}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=P54578-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P54578-2; Sequence=VSP_047343;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=P54578-3; Sequence=VSP_057292;
CC         Note=No experimental confirmation available.;
CC   -!- SIMILARITY: Belongs to the peptidase C19 family. USP14/UBP6
CC       subfamily. {ECO:0000305}.
CC   -!- CAUTION: Was originally (Ref.1) thought to be a guanine tRNA-
CC       ribosyltransferase. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CR976282; Type=Frameshift; Positions=288; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U30888; AAB60365.1; -; mRNA.
DR   EMBL; BT007183; AAP35847.1; -; mRNA.
DR   EMBL; AK297605; BAH12624.1; -; mRNA.
DR   EMBL; AP000845; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC003556; AAH03556.1; -; mRNA.
DR   EMBL; CR976282; -; NOT_ANNOTATED_CDS; mRNA.
DR   CCDS; CCDS32780.1; -. [P54578-1]
DR   CCDS; CCDS32781.1; -. [P54578-2]
DR   PIR; G01932; G01932.
DR   RefSeq; NP_001032411.1; NM_001037334.1. [P54578-2]
DR   RefSeq; NP_005142.1; NM_005151.3. [P54578-1]
DR   UniGene; Hs.464416; -.
DR   UniGene; Hs.707058; -.
DR   PDB; 2AYN; X-ray; 3.20 A; A/B/C=91-494.
DR   PDB; 2AYO; X-ray; 3.50 A; A=91-494.
DR   PDB; 5GJQ; EM; 4.50 A; x=1-494.
DR   PDBsum; 2AYN; -.
DR   PDBsum; 2AYO; -.
DR   PDBsum; 5GJQ; -.
DR   ProteinModelPortal; P54578; -.
DR   SMR; P54578; -.
DR   BioGrid; 114551; 73.
DR   IntAct; P54578; 32.
DR   MINT; MINT-3020275; -.
DR   STRING; 9606.ENSP00000261601; -.
DR   BindingDB; P54578; -.
DR   ChEMBL; CHEMBL1293295; -.
DR   GuidetoPHARMACOLOGY; 2429; -.
DR   MEROPS; C19.015; -.
DR   iPTMnet; P54578; -.
DR   PhosphoSitePlus; P54578; -.
DR   SwissPalm; P54578; -.
DR   BioMuta; USP14; -.
DR   DMDM; 1729927; -.
DR   OGP; P54578; -.
DR   EPD; P54578; -.
DR   MaxQB; P54578; -.
DR   PaxDb; P54578; -.
DR   PeptideAtlas; P54578; -.
DR   PRIDE; P54578; -.
DR   DNASU; 9097; -.
DR   Ensembl; ENST00000261601; ENSP00000261601; ENSG00000101557. [P54578-1]
DR   Ensembl; ENST00000400266; ENSP00000383125; ENSG00000101557. [P54578-3]
DR   Ensembl; ENST00000582707; ENSP00000464447; ENSG00000101557. [P54578-2]
DR   GeneID; 9097; -.
DR   KEGG; hsa:9097; -.
DR   UCSC; uc002kkf.2; human. [P54578-1]
DR   CTD; 9097; -.
DR   DisGeNET; 9097; -.
DR   GeneCards; USP14; -.
DR   HGNC; HGNC:12612; USP14.
DR   HPA; HPA001308; -.
DR   MIM; 607274; gene.
DR   neXtProt; NX_P54578; -.
DR   OpenTargets; ENSG00000101557; -.
DR   PharmGKB; PA37238; -.
DR   eggNOG; KOG1872; Eukaryota.
DR   eggNOG; ENOG410XP96; LUCA.
DR   GeneTree; ENSGT00390000009615; -.
DR   HOGENOM; HOG000202292; -.
DR   HOVERGEN; HBG054185; -.
DR   InParanoid; P54578; -.
DR   KO; K11843; -.
DR   OMA; FKVKVKW; -.
DR   OrthoDB; EOG091G06MR; -.
DR   PhylomeDB; P54578; -.
DR   TreeFam; TF314494; -.
DR   Reactome; R-HSA-5689880; Ub-specific processing proteases.
DR   ChiTaRS; USP14; human.
DR   EvolutionaryTrace; P54578; -.
DR   GeneWiki; USP14; -.
DR   GenomeRNAi; 9097; -.
DR   PRO; PR:P54578; -.
DR   Proteomes; UP000005640; Chromosome 18.
DR   Bgee; ENSG00000101557; -.
DR   CleanEx; HS_USP14; -.
DR   ExpressionAtlas; P54578; baseline and differential.
DR   Genevisible; P54578; HS.
DR   GO; GO:0009986; C:cell surface; IDA:UniProtKB.
DR   GO; GO:0031410; C:cytoplasmic vesicle; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0000502; C:proteasome complex; IEA:UniProtKB-KW.
DR   GO; GO:0045202; C:synapse; IEA:Ensembl.
DR   GO; GO:0004197; F:cysteine-type endopeptidase activity; TAS:ProtInc.
DR   GO; GO:0004866; F:endopeptidase inhibitor activity; IMP:UniProtKB.
DR   GO; GO:0070628; F:proteasome binding; IDA:UniProtKB.
DR   GO; GO:0004843; F:thiol-dependent ubiquitin-specific protease activity; IDA:FlyBase.
DR   GO; GO:0008193; F:tRNA guanylyltransferase activity; TAS:ProtInc.
DR   GO; GO:0007268; P:chemical synaptic transmission; IEA:Ensembl.
DR   GO; GO:1903070; P:negative regulation of ER-associated ubiquitin-dependent protein catabolic process; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0016579; P:protein deubiquitination; IDA:FlyBase.
DR   GO; GO:0050920; P:regulation of chemotaxis; IMP:UniProtKB.
DR   GO; GO:0061136; P:regulation of proteasomal protein catabolic process; IMP:UniProtKB.
DR   GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro.
DR   InterPro; IPR001394; Peptidase_C19_UCH.
DR   InterPro; IPR029071; Ubiquitin-rel_dom.
DR   InterPro; IPR019954; Ubiquitin_CS.
DR   InterPro; IPR000626; Ubiquitin_dom.
DR   InterPro; IPR018200; USP_CS.
DR   InterPro; IPR028889; USP_dom.
DR   Pfam; PF00443; UCH; 1.
DR   SMART; SM00213; UBQ; 1.
DR   SUPFAM; SSF54236; SSF54236; 1.
DR   PROSITE; PS00299; UBIQUITIN_1; 1.
DR   PROSITE; PS50053; UBIQUITIN_2; 1.
DR   PROSITE; PS00972; USP_1; 1.
DR   PROSITE; PS00973; USP_2; 1.
DR   PROSITE; PS50235; USP_3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Cell membrane;
KW   Complete proteome; Cytoplasm; Hydrolase; Membrane; Phosphoprotein;
KW   Protease; Proteasome; Reference proteome; Thiol protease;
KW   Ubl conjugation pathway.
FT   CHAIN         1    494       Ubiquitin carboxyl-terminal hydrolase 14.
FT                                /FTId=PRO_0000080636.
FT   DOMAIN        4     80       Ubiquitin-like. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00214}.
FT   DOMAIN      105    483       USP.
FT   ACT_SITE    114    114       Nucleophile.
FT                                {ECO:0000305|PubMed:16211010}.
FT   ACT_SITE    435    435       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU10092, ECO:0000255|PROSITE-
FT                                ProRule:PRU10093}.
FT   MOD_RES      52     52       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     143    143       Phosphoserine.
FT                                {ECO:0000244|PubMed:19367720,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     148    148       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9JMA1}.
FT   MOD_RES     235    235       Phosphothreonine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     237    237       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     302    302       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     432    432       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     449    449       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   VAR_SEQ      55     65       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_057292.
FT   VAR_SEQ      66    100       Missing (in isoform 2).
FT                                {ECO:0000303|Ref.6}.
FT                                /FTId=VSP_047343.
FT   STRAND      110    112       {ECO:0000244|PDB:2AYO}.
FT   HELIX       114    124       {ECO:0000244|PDB:2AYN}.
FT   HELIX       127    134       {ECO:0000244|PDB:2AYN}.
FT   STRAND      144    147       {ECO:0000244|PDB:2AYO}.
FT   HELIX       148    166       {ECO:0000244|PDB:2AYN}.
FT   STRAND      168    170       {ECO:0000244|PDB:2AYN}.
FT   HELIX       173    182       {ECO:0000244|PDB:2AYN}.
FT   HELIX       184    187       {ECO:0000244|PDB:2AYN}.
FT   HELIX       200    212       {ECO:0000244|PDB:2AYN}.
FT   HELIX       242    246       {ECO:0000244|PDB:2AYN}.
FT   STRAND      249    260       {ECO:0000244|PDB:2AYN}.
FT   STRAND      269    278       {ECO:0000244|PDB:2AYN}.
FT   STRAND      280    282       {ECO:0000244|PDB:2AYN}.
FT   HELIX       286    292       {ECO:0000244|PDB:2AYN}.
FT   STRAND      297    301       {ECO:0000244|PDB:2AYO}.
FT   TURN        303    306       {ECO:0000244|PDB:2AYN}.
FT   STRAND      311    319       {ECO:0000244|PDB:2AYN}.
FT   STRAND      322    329       {ECO:0000244|PDB:2AYN}.
FT   STRAND      336    339       {ECO:0000244|PDB:2AYN}.
FT   STRAND      351    354       {ECO:0000244|PDB:2AYN}.
FT   HELIX       356    358       {ECO:0000244|PDB:2AYN}.
FT   HELIX       361    366       {ECO:0000244|PDB:2AYN}.
FT   TURN        367    371       {ECO:0000244|PDB:2AYN}.
FT   HELIX       372    374       {ECO:0000244|PDB:2AYN}.
FT   TURN        409    412       {ECO:0000244|PDB:2AYN}.
FT   STRAND      416    430       {ECO:0000244|PDB:2AYN}.
FT   STRAND      433    443       {ECO:0000244|PDB:2AYN}.
FT   STRAND      446    451       {ECO:0000244|PDB:2AYN}.
FT   STRAND      454    458       {ECO:0000244|PDB:2AYO}.
FT   HELIX       460    463       {ECO:0000244|PDB:2AYN}.
FT   HELIX       464    467       {ECO:0000244|PDB:2AYN}.
FT   STRAND      468    472       {ECO:0000244|PDB:2AYN}.
FT   STRAND      474    481       {ECO:0000244|PDB:2AYN}.
SQ   SEQUENCE   494 AA;  56069 MW;  E6D4679A86E9DF00 CRC64;
     MPLYSVTVKW GKEKFEGVEL NTDEPPMVFK AQLFALTGVQ PARQKVMVKG GTLKDDDWGN
     IKIKNGMTLL MMGSADALPE EPSAKTVFVE DMTEEQLASA MELPCGLTNL GNTCYMNATV
     QCIRSVPELK DALKRYAGAL RASGEMASAQ YITAALRDLF DSMDKTSSSI PPIILLQFLH
     MAFPQFAEKG EQGQYLQQDA NECWIQMMRV LQQKLEAIED DSVKETDSSS ASAATPSKKK
     SLIDQFFGVE FETTMKCTES EEEEVTKGKE NQLQLSCFIN QEVKYLFTGL KLRLQEEITK
     QSPTLQRNAL YIKSSKISRL PAYLTIQMVR FFYKEKESVN AKVLKDVKFP LMLDMYELCT
     PELQEKMVSF RSKFKDLEDK KVNQQPNTSD KKSSPQKEVK YEPFSFADDI GSNNCGYYDL
     QAVLTHQGRS SSSGHYVSWV KRKQDEWIKF DDDKVSIVTP EDILRLSGGG DWHIAYVLLY
     GPRRVEIMEE ESEQ
//
